ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,009 Cr | ₹16,851 Cr | ₹1,347 Cr | ₹1,212 Cr | ₹1,074 Cr |
What is the latest Revenue of ERIS LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,009 Cr |
| Mar2024 | ₹16,851 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹1,212 Cr |
| Mar2021 | ₹1,074 Cr |
How is Revenue of ERIS LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,009 Cr | -88.08 | |
| Mar2024 | ₹16,851 Cr | 1,151.00 | |
| Mar2023 | ₹1,347 Cr | 11.15 | |
| Mar2022 | ₹1,212 Cr | 12.83 | |
| Mar2021 | ₹1,074 Cr | - | |
Compare Revenue of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,138.6 Cr | -1.3% | -5.9% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1.3% |
-5.9% |
-25.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses